시장조사보고서

세계의 생물 제제와 바이오시밀러 시장 2018 Global Biologics and Biosimilars Market Research Report 2018

  • cover image
  • 상품 코드 : 375495
  • 리서치사 : QYResearch
  • 발행일 : 2018년 07월
  • 페이지 정보 : 영문 109 Pages
  • 배송 : 3~5 영업일 이내
  • 가격 :

요약

세계, 특히 북미, 유럽, 중국, 일본 등의 생물 제제와 바이오시밀러 산업에 대해 조사했으며, 주요 제조업체 현황, 지역·제품 종류·용도별 시장 동향(생산량, 가격, 매출, 시장 점유율, 성장률 등) 분석/예측 결과를 정리하여 전해드립니다.

1 생물 제제와 바이오시밀러 시장 개요

2 세계의 생물 제제와 바이오시밀러 시장 경쟁 : 제조업체별

3 세계의 생물 제제와 바이오시밀러 생산능력, 생산량, 매출(가격) : 지역별 (2013-2018)

4 Global 생물 제제와 바이오시밀러 Supply (Production), Consumption, Export, Import by Region (2013-2018)

5 세계의 생물 제제와 바이오시밀러 생산량, 매출(액수), 가격 동향 : 제품 종류별

6 세계의 생물 제제와 바이오시밀러 시장 분석 : 용도별

7 생물 제제와 바이오시밀러 제조업체 개요/분석

  • 7.1 Pfizer
  • 7.2 Roche
  • 7.3 Amgen
  • 7.4 AbbVie
  • 7.5 Sanofi
  • 7.6 Johnson & Johnson
  • 7.7 Novo Nordisk
  • 7.8 Novartis
  • 7.9 Merck
  • 7.10 Lilly
  • 7.11 3sbio
  • 7.12 Changchun High Tech
  • 7.13 CP Guojian Pharmacy
  • 7.14 Biotech Pharma
  • 7.15 Gelgen Biopharma
  • 7.16 Sandoz
  • 7.17 Teva
  • 7.18 Hospira
  • 7.19 Mylan

8 생물 제제와 바이오시밀러 제조 비용 분석

9 산업체인, 구매 전략, 다운스트림(Downstream) 구매자

10 마케팅 전략 분석, 유통업체/수출입업체

11 시장 영향요인 분석

12 생물 제제와 바이오시밀러 세계 시장 예측 (2018-2025)

13 조사 소견과 결론

14 부록


목차

This report studies the global Biologics and Biosimilars market status and forecast, categorizes the global Biologics and Biosimilars market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Biologics and Biosimilars market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report

  • Pfizer
  • Roche
  • Amgen
  • AbbVie
  • Sanofi
  • Johnson & Johnson
  • Novo Nordisk
  • Novartis
  • Merck
  • Lilly
  • 3sbio
  • Changchun High Tech
  • CP Guojian Pharmacy
  • Biotech Pharma
  • Gelgen Biopharma
  • Sandoz
  • Teva
  • Hospira
  • Mylan

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India

We can also provide the customized separate regional or country-level reports, for the following regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Singapore
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Central & South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

  • Antibiotic
  • Enzyme
  • Hormone
  • Non-Patented Biological Reagents
  • Other

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

  • Tumor
  • Diabetes
  • Cardiovascular
  • Hemophilia
  • Other

The study objectives of this report are:

  • To analyze and study the global Biologics and Biosimilars sales, value, status (2013-2017) and forecast (2018-2025).
  • Focuses on the key Biologics and Biosimilars manufacturers, to study the sales, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biologics and Biosimilars are as follows:

  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Biologics and Biosimilars Manufacturers

Biologics and Biosimilars Distributors/Traders/Wholesalers

Biologics and Biosimilars Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Biologics and Biosimilars market, by end-use.

Detailed analysis and profiles of additional market players.

Table of Contents

1 Biologics and Biosimilars Market Overview

  • 1.1 Product Overview and Scope of Biologics and Biosimilars
  • 1.2 Biologics and Biosimilars Segment by Type (Product Category)
    • 1.2.1 Global Biologics and Biosimilars Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
    • 1.2.2 Global Biologics and Biosimilars Production Market Share by Type (Product Category) in 2017
    • 1.2.3 Antibiotic
    • 1.2.4 Enzyme
    • 1.2.5 Hormone
    • 1.2.6 Non-Patented Biological Reagents
    • 1.2.7 Other
  • 1.3 Global Biologics and Biosimilars Segment by Application
    • 1.3.1 Biologics and Biosimilars Consumption (Sales) Comparison by Application (2013-2025)
    • 1.3.2 Tumor
    • 1.3.3 Diabetes
    • 1.3.4 Cardiovascular
    • 1.3.5 Hemophilia
    • 1.3.6 Other
  • 1.4 Global Biologics and Biosimilars Market by Region (2013-2025)
    • 1.4.1 Global Biologics and Biosimilars Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
    • 1.4.2 North America Status and Prospect (2013-2025)
    • 1.4.3 Europe Status and Prospect (2013-2025)
    • 1.4.4 China Status and Prospect (2013-2025)
    • 1.4.5 Japan Status and Prospect (2013-2025)
    • 1.4.6 Southeast Asia Status and Prospect (2013-2025)
    • 1.4.7 India Status and Prospect (2013-2025)
  • 1.5 Global Market Size (Value) of Biologics and Biosimilars (2013-2025)
    • 1.5.1 Global Biologics and Biosimilars Revenue Status and Outlook (2013-2025)
    • 1.5.2 Global Biologics and Biosimilars Capacity, Production Status and Outlook (2013-2025)

2 Global Biologics and Biosimilars Market Competition by Manufacturers

  • 2.1 Global Biologics and Biosimilars Capacity, Production and Share by Manufacturers (2013-2018)
    • 2.1.1 Global Biologics and Biosimilars Capacity and Share by Manufacturers (2013-2018)
    • 2.1.2 Global Biologics and Biosimilars Production and Share by Manufacturers (2013-2018)
  • 2.2 Global Biologics and Biosimilars Revenue and Share by Manufacturers (2013-2018)
  • 2.3 Global Biologics and Biosimilars Average Price by Manufacturers (2013-2018)
  • 2.4 Manufacturers Biologics and Biosimilars Manufacturing Base Distribution, Sales Area and Product Type
  • 2.5 Biologics and Biosimilars Market Competitive Situation and Trends
    • 2.5.1 Biologics and Biosimilars Market Concentration Rate
    • 2.5.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers
    • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Biologics and Biosimilars Capacity, Production, Revenue (Value) by Region (2013-2018)

  • 3.1 Global Biologics and Biosimilars Capacity and Market Share by Region (2013-2018)
  • 3.2 Global Biologics and Biosimilars Production and Market Share by Region (2013-2018)
  • 3.3 Global Biologics and Biosimilars Revenue (Value) and Market Share by Region (2013-2018)
  • 3.4 Global Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  • 3.5 North America Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  • 3.6 Europe Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  • 3.7 China Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  • 3.8 Japan Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  • 3.9 Southeast Asia Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  • 3.10 India Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Biologics and Biosimilars Supply (Production), Consumption, Export, Import by Region (2013-2018)

  • 4.1 Global Biologics and Biosimilars Consumption by Region (2013-2018)
  • 4.2 North America Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)
  • 4.3 Europe Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)
  • 4.4 China Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)
  • 4.5 Japan Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)
  • 4.6 Southeast Asia Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)
  • 4.7 India Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)

5 Global Biologics and Biosimilars Production, Revenue (Value), Price Trend by Type

  • 5.1 Global Biologics and Biosimilars Production and Market Share by Type (2013-2018)
  • 5.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2013-2018)
  • 5.3 Global Biologics and Biosimilars Price by Type (2013-2018)
  • 5.4 Global Biologics and Biosimilars Production Growth by Type (2013-2018)

6 Global Biologics and Biosimilars Market Analysis by Application

  • 6.1 Global Biologics and Biosimilars Consumption and Market Share by Application (2013-2018)
  • 6.2 Global Biologics and Biosimilars Consumption Growth Rate by Application (2013-2018)
  • 6.3 Market Drivers and Opportunities
    • 6.3.1 Potential Applications
    • 6.3.2 Emerging Markets/Countries

7 Global Biologics and Biosimilars Manufacturers Profiles/Analysis

  • 7.1 Pfizer
    • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.1.2 Biologics and Biosimilars Product Category, Application and Specification
      • 7.1.2.1 Product A
      • 7.1.2.2 Product B
    • 7.1.3 Pfizer Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.1.4 Main Business/Business Overview
  • 7.2 Roche
    • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.2.2 Biologics and Biosimilars Product Category, Application and Specification
      • 7.2.2.1 Product A
      • 7.2.2.2 Product B
    • 7.2.3 Roche Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.2.4 Main Business/Business Overview
  • 7.3 Amgen
    • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.3.2 Biologics and Biosimilars Product Category, Application and Specification
      • 7.3.2.1 Product A
      • 7.3.2.2 Product B
    • 7.3.3 Amgen Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.3.4 Main Business/Business Overview
  • 7.4 AbbVie
    • 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.4.2 Biologics and Biosimilars Product Category, Application and Specification
      • 7.4.2.1 Product A
      • 7.4.2.2 Product B
    • 7.4.3 AbbVie Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.4.4 Main Business/Business Overview
  • 7.5 Sanofi
    • 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.5.2 Biologics and Biosimilars Product Category, Application and Specification
      • 7.5.2.1 Product A
      • 7.5.2.2 Product B
    • 7.5.3 Sanofi Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
    • 7.5.4 Main Business/Business Overview
  • 7.6 Johnson & Johnson
    • 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.6.2 Biologics and Biosimilars Product Category, Application and Specification
      • 7.6.2.1 Product A
      • 7.6.2.2 Product B
    • 7.6.3 Johnson & Johnson Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.6.4 Main Business/Business Overview
  • 7.7 Novo Nordisk
    • 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.7.2 Biologics and Biosimilars Product Category, Application and Specification
      • 7.7.2.1 Product A
      • 7.7.2.2 Product B
    • 7.7.3 Novo Nordisk Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.7.4 Main Business/Business Overview
  • 7.8 Novartis
    • 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.8.2 Biologics and Biosimilars Product Category, Application and Specification
      • 7.8.2.1 Product A
      • 7.8.2.2 Product B
    • 7.8.3 Novartis Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.8.4 Main Business/Business Overview
  • 7.9 Merck
    • 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.9.2 Biologics and Biosimilars Product Category, Application and Specification
      • 7.9.2.1 Product A
      • 7.9.2.2 Product B
    • 7.9.3 Merck Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.9.4 Main Business/Business Overview
  • 7.10 Lilly
    • 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.10.2 Biologics and Biosimilars Product Category, Application and Specification
      • 7.10.2.1 Product A
      • 7.10.2.2 Product B
    • 7.10.3 Lilly Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
    • 7.10.4 Main Business/Business Overview
  • 7.11 3sbio
  • 7.12 Changchun High Tech
  • 7.13 CP Guojian Pharmacy
  • 7.14 Biotech Pharma
  • 7.15 Gelgen Biopharma
  • 7.16 Sandoz
  • 7.17 Teva
  • 7.18 Hospira
  • 7.19 Mylan

8 Biologics and Biosimilars Manufacturing Cost Analysis

  • 8.1 Biologics and Biosimilars Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Price Trend of Key Raw Materials
    • 8.1.3 Key Suppliers of Raw Materials
    • 8.1.4 Market Concentration Rate of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
    • 8.2.1 Raw Materials
    • 8.2.2 Labor Cost
    • 8.2.3 Manufacturing Expenses
  • 8.3 Manufacturing Process Analysis of Biologics and Biosimilars

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

  • 9.1 Biologics and Biosimilars Industrial Chain Analysis
  • 9.2 Upstream Raw Materials Sourcing
  • 9.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2017
  • 9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

  • 10.1 Marketing Channel
    • 10.1.1 Direct Marketing
    • 10.1.2 Indirect Marketing
    • 10.1.3 Marketing Channel Development Trend
  • 10.2 Market Positioning
    • 10.2.1 Pricing Strategy
    • 10.2.2 Brand Strategy
    • 10.2.3 Target Client
  • 10.3 Distributors/Traders List

11 Market Effect Factors Analysis

  • 11.1 Technology Progress/Risk
    • 11.1.1 Substitutes Threat
    • 11.1.2 Technology Progress in Related Industry
  • 11.2 Consumer Needs/Customer Preference Change
  • 11.3 Economic/Political Environmental Change

12 Global Biologics and Biosimilars Market Forecast (2018-2025)

  • 12.1 Global Biologics and Biosimilars Capacity, Production, Revenue Forecast (2018-2025)
    • 12.1.1 Global Biologics and Biosimilars Capacity, Production and Growth Rate Forecast (2018-2025)
    • 12.1.2 Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2018-2025)
    • 12.1.3 Global Biologics and Biosimilars Price and Trend Forecast (2018-2025)
  • 12.2 Global Biologics and Biosimilars Production, Consumption , Import and Export Forecast by Region (2018-2025)
    • 12.2.1 North America Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    • 12.2.2 Europe Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    • 12.2.3 China Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    • 12.2.4 Japan Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    • 12.2.5 Southeast Asia Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    • 12.2.6 India Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  • 12.3 Global Biologics and Biosimilars Production, Revenue and Price Forecast by Type (2018-2025)
  • 12.4 Global Biologics and Biosimilars Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix

  • 14.1 Methodology/Research Approach
    • 14.1.1 Research Programs/Design
    • 14.1.2 Market Size Estimation
    • 14.1.3 Market Breakdown and Data Triangulation
  • 14.2 Data Source
    • 14.2.1 Secondary Sources
    • 14.2.2 Primary Sources
  • 14.3 Disclaimer

List of Tables and Figures

  • Figure Picture of Biologics and Biosimilars
  • Figure Global Biologics and Biosimilars Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
  • Figure Global Biologics and Biosimilars Production Market Share by Types (Product Category) in 2017
  • Figure Product Picture of Antibiotic
  • Table Major Manufacturers of Antibiotic
  • Figure Product Picture of Enzyme
  • Table Major Manufacturers of Enzyme
  • Figure Product Picture of Hormone
  • Table Major Manufacturers of Hormone
  • Figure Product Picture of Non-Patented Biological Reagents
  • Table Major Manufacturers of Non-Patented Biological Reagents
  • Figure Product Picture of Other
  • Table Major Manufacturers of Other
  • Figure Global Biologics and Biosimilars Consumption (K Units) by Applications (2013-2025)
  • Figure Global Biologics and Biosimilars Consumption Market Share by Applications in 2017
  • Figure Tumor Examples
  • Table Key Downstream Customer in Tumor
  • Figure Diabetes Examples
  • Table Key Downstream Customer in Diabetes
  • Figure Cardiovascular Examples
  • Table Key Downstream Customer in Cardiovascular
  • Figure Hemophilia Examples
  • Table Key Downstream Customer in Hemophilia
  • Figure Other Examples
  • Table Key Downstream Customer in Other
  • Figure Global Biologics and Biosimilars Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
  • Figure North America Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Global Biologics and Biosimilars Revenue (Million USD) Status and Outlook (2013-2025)
  • Figure Global Biologics and Biosimilars Capacity, Production (K Units) Status and Outlook (2013-2025)
  • Figure Global Biologics and Biosimilars Major Players Product Capacity (K Units) (2013-2018)
  • Table Global Biologics and Biosimilars Capacity (K Units) of Key Manufacturers (2013-2018)
  • Table Global Biologics and Biosimilars Capacity Market Share of Key Manufacturers (2013-2018)
  • Figure Global Biologics and Biosimilars Capacity (K Units) of Key Manufacturers in 2017
  • Figure Global Biologics and Biosimilars Capacity (K Units) of Key Manufacturers in 2018
  • Figure Global Biologics and Biosimilars Major Players Product Production (K Units) (2013-2018)
  • Table Global Biologics and Biosimilars Production (K Units) of Key Manufacturers (2013-2018)
  • Table Global Biologics and Biosimilars Production Share by Manufacturers (2013-2018)
  • Figure 2017 Biologics and Biosimilars Production Share by Manufacturers
  • Figure 2017 Biologics and Biosimilars Production Share by Manufacturers
  • Figure Global Biologics and Biosimilars Major Players Product Revenue (Million USD) (2013-2018)
  • Table Global Biologics and Biosimilars Revenue (Million USD) by Manufacturers (2013-2018)
  • Table Global Biologics and Biosimilars Revenue Share by Manufacturers (2013-2018)
  • Table 2017 Global Biologics and Biosimilars Revenue Share by Manufacturers
  • Table 2018 Global Biologics and Biosimilars Revenue Share by Manufacturers
  • Table Global Market Biologics and Biosimilars Average Price (USD/Unit) of Key Manufacturers (2013-2018)
  • Figure Global Market Biologics and Biosimilars Average Price (USD/Unit) of Key Manufacturers in 2017
  • Table Manufacturers Biologics and Biosimilars Manufacturing Base Distribution and Sales Area
  • Table Manufacturers Biologics and Biosimilars Product Category
  • Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers
  • Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers
  • Table Global Biologics and Biosimilars Capacity (K Units) by Region (2013-2018)
  • Figure Global Biologics and Biosimilars Capacity Market Share by Region (2013-2018)
  • Figure Global Biologics and Biosimilars Capacity Market Share by Region (2013-2018)
  • Figure 2017 Global Biologics and Biosimilars Capacity Market Share by Region
  • Table Global Biologics and Biosimilars Production by Region (2013-2018)
  • Figure Global Biologics and Biosimilars Production (K Units) by Region (2013-2018)
  • Figure Global Biologics and Biosimilars Production Market Share by Region (2013-2018)
  • Figure 2017 Global Biologics and Biosimilars Production Market Share by Region
  • Table Global Biologics and Biosimilars Revenue (Million USD) by Region (2013-2018)
  • Table Global Biologics and Biosimilars Revenue Market Share by Region (2013-2018)
  • Figure Global Biologics and Biosimilars Revenue Market Share by Region (2013-2018)
  • Table 2017 Global Biologics and Biosimilars Revenue Market Share by Region
  • Figure Global Biologics and Biosimilars Capacity, Production (K Units) and Growth Rate (2013-2018)
  • Table Global Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table North America Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Europe Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table China Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Japan Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table China Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Japan Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Global Biologics and Biosimilars Consumption (K Units) Market by Region (2013-2018)
  • Table Global Biologics and Biosimilars Consumption Market Share by Region (2013-2018)
  • Figure Global Biologics and Biosimilars Consumption Market Share by Region (2013-2018)
  • Figure 2017 Global Biologics and Biosimilars Consumption (K Units) Market Share by Region
  • Table North America Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
  • Table Europe Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
  • Table China Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
  • Table Japan Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
  • Table Southeast Asia Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
  • Table India Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)
  • Table Global Biologics and Biosimilars Production (K Units) by Type (2013-2018)
  • Table Global Biologics and Biosimilars Production Share by Type (2013-2018)
  • Figure Production Market Share of Biologics and Biosimilars by Type (2013-2018)
  • Figure 2017 Production Market Share of Biologics and Biosimilars by Type
  • Table Global Biologics and Biosimilars Revenue (Million USD) by Type (2013-2018)
  • Table Global Biologics and Biosimilars Revenue Share by Type (2013-2018)
  • Figure Production Revenue Share of Biologics and Biosimilars by Type (2013-2018)
  • Figure 2017 Revenue Market Share of Biologics and Biosimilars by Type
  • Table Global Biologics and Biosimilars Price (USD/Unit) by Type (2013-2018)
  • Figure Global Biologics and Biosimilars Production Growth by Type (2013-2018)
  • Table Global Biologics and Biosimilars Consumption (K Units) by Application (2013-2018)
  • Table Global Biologics and Biosimilars Consumption Market Share by Application (2013-2018)
  • Figure Global Biologics and Biosimilars Consumption Market Share by Applications (2013-2018)
  • Figure Global Biologics and Biosimilars Consumption Market Share by Application in 2017
  • Table Global Biologics and Biosimilars Consumption Growth Rate by Application (2013-2018)
  • Figure Global Biologics and Biosimilars Consumption Growth Rate by Application (2013-2018)
  • Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Pfizer Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (Pfizer) and Gross Margin (2013-2018)
  • Figure Pfizer Biologics and Biosimilars Production Growth Rate (2013-2018)
  • Figure Pfizer Biologics and Biosimilars Production Market Share (2013-2018)
  • Figure Pfizer Biologics and Biosimilars Revenue Market Share (2013-2018)
  • Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Roche Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Roche Biologics and Biosimilars Production Growth Rate (2013-2018)
  • Figure Roche Biologics and Biosimilars Production Market Share (2013-2018)
  • Figure Roche Biologics and Biosimilars Revenue Market Share (2013-2018)
  • Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Amgen Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Amgen Biologics and Biosimilars Production Growth Rate (2013-2018)
  • Figure Amgen Biologics and Biosimilars Production Market Share (2013-2018)
  • Figure Amgen Biologics and Biosimilars Revenue Market Share (2013-2018)
  • Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table AbbVie Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure AbbVie Biologics and Biosimilars Production Growth Rate (2013-2018)
  • Figure AbbVie Biologics and Biosimilars Production Market Share (2013-2018)
  • Figure AbbVie Biologics and Biosimilars Revenue Market Share (2013-2018)
  • Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Sanofi Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Sanofi Biologics and Biosimilars Production Growth Rate (2013-2018)
  • Figure Sanofi Biologics and Biosimilars Production Market Share (2013-2018)
  • Figure Sanofi Biologics and Biosimilars Revenue Market Share (2013-2018)
  • Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Johnson & Johnson Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Johnson & Johnson Biologics and Biosimilars Production Growth Rate (2013-2018)
  • Figure Johnson & Johnson Biologics and Biosimilars Production Market Share (2013-2018)
  • Figure Johnson & Johnson Biologics and Biosimilars Revenue Market Share (2013-2018)
  • Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Novo Nordisk Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Novo Nordisk Biologics and Biosimilars Production Growth Rate (2013-2018)
  • Figure Novo Nordisk Biologics and Biosimilars Production Market Share (2013-2018)
  • Figure Novo Nordisk Biologics and Biosimilars Revenue Market Share (2013-2018)
  • Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Novartis Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Novartis Biologics and Biosimilars Production Growth Rate (2013-2018)
  • Figure Novartis Biologics and Biosimilars Production Market Share (2013-2018)
  • Figure Novartis Biologics and Biosimilars Revenue Market Share (2013-2018)
  • Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Merck Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Merck Biologics and Biosimilars Production Growth Rate (2013-2018)
  • Figure Merck Biologics and Biosimilars Production Market Share (2013-2018)
  • Figure Merck Biologics and Biosimilars Revenue Market Share (2013-2018)
  • Table Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Lilly Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Lilly Biologics and Biosimilars Production Growth Rate (2013-2018)
  • Figure Lilly Biologics and Biosimilars Production Market Share (2013-2018)
  • Figure Lilly Biologics and Biosimilars Revenue Market Share (2013-2018)
  • Table Production Base and Market Concentration Rate of Raw Material
  • Figure Price Trend of Key Raw Materials
  • Table Key Suppliers of Raw Materials
  • Figure Manufacturing Cost Structure of Biologics and Biosimilars
  • Figure Manufacturing Process Analysis of Biologics and Biosimilars
  • Figure Biologics and Biosimilars Industrial Chain Analysis
  • Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2017
  • Table Major Buyers of Biologics and Biosimilars
  • Table Distributors/Traders List
  • Figure Global Biologics and Biosimilars Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
  • Figure Global Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Figure Global Biologics and Biosimilars Price (Million USD) and Trend Forecast (2018-2025)
  • Table Global Biologics and Biosimilars Production (K Units) Forecast by Region (2018-2025)
  • Figure Global Biologics and Biosimilars Production Market Share Forecast by Region (2018-2025)
  • Table Global Biologics and Biosimilars Consumption (K Units) Forecast by Region (2018-2025)
  • Figure Global Biologics and Biosimilars Consumption Market Share Forecast by Region (2018-2025)
  • Figure North America Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
  • Figure North America Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Table North America Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
  • Figure Europe Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
  • Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Table Europe Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
  • Figure China Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
  • Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Table China Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
  • Figure Japan Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
  • Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Table Japan Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
  • Figure Southeast Asia Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
  • Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Table Southeast Asia Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
  • Figure India Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)
  • Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Table India Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
  • Table Global Biologics and Biosimilars Production (K Units) Forecast by Type (2018-2025)
  • Figure Global Biologics and Biosimilars Production (K Units) Forecast by Type (2018-2025)
  • Table Global Biologics and Biosimilars Revenue (Million USD) Forecast by Type (2018-2025)
  • Figure Global Biologics and Biosimilars Revenue Market Share Forecast by Type (2018-2025)
  • Table Global Biologics and Biosimilars Price Forecast by Type (2018-2025)
  • Table Global Biologics and Biosimilars Consumption (K Units) Forecast by Application (2018-2025)
  • Figure Global Biologics and Biosimilars Consumption (K Units) Forecast by Application (2018-2025)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Source

생물 제제와 바이오시밀러 관련자료

TOP
회사소개 이용약관 개인정보 처리방침 사이트맵

© Copyright 2011-2018, Global Information, Inc. All rights reserved.